Document reference

2013/2903(DEA)  
Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment  
Basic information  

2013/2903(DEA)

DEA - Delegated acts procedure

Supplementing 2008/0240(COD)

Subject
3.40.06 Electronics, electrotechnical industries, ICT, robotics
3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)

Status

Procedure completed - delegated act enters into force

 

Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
Key events  
18/10/2013
Non-legislative basic document published
C(2013)06794
18/10/2013
Initial period for examining delegated act 2 month(s)
23/10/2013
Committee referral announced in Parliament, 1st reading/single reading
19/12/2013
Delegated act not objected by Council
07/01/2014
Delegated act not objected by Parliament
Technical information  
Procedure reference
2013/2903(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/7/14362
Documentation gateway  
  • European Commission 
    Non-legislative basic document
     
    C(2013)06794
    18/10/2013
    EC
     
  • All 
    Non-legislative basic document
       
    C(2013)06794
    18/10/2013
    EC